SUMMARY Basal plasmin and thrombin activity in plasma were assessed by radioimmunoassay of the fibrinogen derivatives containing the sequence BPf,,12 and of fibrinopeptide A respectively in a cross sectional controlled study of men with coronary artery disease. Compared with healthy controls (n = 33) men with angiographically defined coronary artery disease (n = 98) had a modest but significant increase in concentrations of fibrinopeptide A, indicating an activated coagulation system. Concentrations of B#f542 were similar in those with coronary artery disease and in the controls.
coagulation system. Concentrations of B#f542 were similar in those with coronary artery disease and in the controls.
The enhanced thrombin activity in coronary artery disease is in keeping with current evidence suggesting an association between coronary artery disease and a hypercoagulable state.
Recent interest in the role of haemostasis in vascular disease was prompted by studies showing an association between haemostatic variables and ischaemic heart disease'`and by prospective studies which show that increased fibrinogen, in particular, is associated with ischaemic heart disease.' Sensitive radioimmunoassays have become available for measurement of the fibrinogen derivatives, fibrinopeptide A (an indicator of thrombin degradation of fibrinogen in vivo) and Bfi,2-containing peptides (an indicator of plasmin mediated fibrin(ogen)-olysis). Simultaneous measurement of these peptides permits the balance between fibrinolysis and coagulation to be estimated. Since it has been postulated that the patency of the vascular system depends on the dynamic equilibrium between fibrinolysis and coagulation,7 these peptides could provide a measure of the risk of thrombosis.8 Compared with control subjects, fibrinopeptide A concentrations have been reported to be raised9 or normal"0 in subjects with ischaemic heart disease. The concentrations of Bf,i,2 peptides in patients with coronary artery disease have not been studied and therefore we have measured these fibrinogen derivatives in a controlled study to establish whether coronary artery disease is associated with an imbalance between fibrinolysis and coagulation.
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Accepted for publication 18 May 1988 Patients and methods Informed consent was obtained from 98 white men who had been admitted for elective coronary angiography for investigation of ischaemic cardiac pain. Because acute arterial vascular events have been shown to alter some tests of haemostasis" 12 we excluded patients who had sustained a myocardial infarction within three months ofcoronary investigation. We studied a control group of 33 white, healthy factory employees. These men lived in the same area as the patients with coronary disease. The control subjects were not receiving any drug treatment, were not hypertensive (blood pressure < 160/95 mm Hg), and gave no family history of ischaemic heart disease or diabetes mellitus. Random urinalysis and the measurement of concentrations of plasma glucose in fasting subjects excluded undiagnosed asymptomatic diabetes mellitus. The body mass index (weight (kg)/ height (m2)) was calculated as a measure of overweight or underweight. '3 METHODS A single resting blood sample was taken with minimal venostatis from fasted subjects between 7 and 9 am. Citrated blood was taken for radioimmunoassay of plasma BP,i,2 peptides and fibrinopeptide A (IMCO, Stockholm) as previously described.'4 15 Coronary angiography was performed by the Judkins' technique'6 and blood samples were taken before this procedure. Coronary artery disease was 202 scored as the number of major vessels with a reduction of the luminal diameter of > 50%. STATISTICAL 
ANALYSIS
The distribution of fibrinopeptide A and BP,,2 peptides was skewed. Log transformation provided the best approximation to a normal distribution. The principal aim of the study was to assess whether the peptide concentrations were different in coronary heart disease and this was analysed by the unpaired Students t test on log transformed data. A one factor analysis of variance (ANOVA) was used to assess the effect of the severity of coronary artery disease on the peptide concentrations.
Results
The two groups were well matched for age, body mass index, and smoking ( Thrombin and plasmin activity in coronary artery disease 203 be that dynamic stimuli such as exercise or venous occlusion might unmask defective plasmin activity (as measured by changes in BP5i42 concentrations) in coronary artery disease but this suggestion requires further study. None the less, the results of our study accord with growing evidence that ischaemic heart disease is associated with haemostatic disturbance.`' We thank Dr G Gettinby for statistical advice.
